MSD OSS B.V.
17Patents
17Active
17Granted
49Portfolio score
Filing activity: May 19, 2004 → Jul 8, 2014 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8354509B2 | Antibodies to human programmed death receptor PD-1 | Physics | 381 | Active |
| US8227623B2 | Process for the preparation of asenapine and intermediate products used in said process | Chemistry; Metallurgy | 7 | Active |
| US8357679B2 | Hexafluoroisopropanol derivatives | Chemistry; Metallurgy | 7 | Active |
| US8333983B2 | Drug delivery system | Human Necessities | 4 | Active |
| US8211927B2 | 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators | Chemistry; Metallurgy | 2 | Active |
| US8291910B2 | Intrauterine deposit | Emerging Cross-Sectional Technologies | 2 | Active |
| US8168595B2 | Antithrombotic dual inhibitors comprising a biotin residue | Chemistry; Metallurgy | 1 | Active |
| US8802395B2 | Method for protein isolation in anoxic conditions | Chemistry; Metallurgy | 1 | Active |
| US8394789B2 | (Dihydro)pyrrolo[2,1-α]isoquinolines | Chemistry; Metallurgy | 0 | Active |
| US8129397B2 | Substituted thieno[2,3-d]pyrimidines as AMPA modulators | Human Necessities | 0 | Active |
| US8143246B2 | 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives | Chemistry; Metallurgy | 0 | Active |
| US9505802B2 | Method for protein isolation in anoxic conditions | Chemistry; Metallurgy | 0 | Active |
| US8314091B2 | N-benzyl,N'-arylcarbonylpiperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US8273908B2 | Process for the preparation of estrone and/or estradiol-derivatives | Chemistry; Metallurgy | 0 | Active |
| US8367648B2 | Substituted 16,17-annellated steroid compounds for use in womens healthcare | Chemistry; Metallurgy | 0 | Active |
| US8299091B2 | Aminoisoquinoline thrombin inhibitor with improved bioavailability | Chemistry; Metallurgy | 0 | Active |
| US8258293B2 | Tetrahydroquinoline derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.